Dorucin 10mg Injection

About

Epirubicin is an anthracycline cytotoxic agent, structurally and mechanistically similar to doxorubicin, widely employed in the treatment of various cancers. It exerts its potent anti-tumor effects primarily by intercalating into DNA, which disrupts nucleic acid synthesis, and by inhibiting topoisomerase II, an enzyme vital for DNA replication and repair. Additionally, epirubicin generates free radicals that cause oxidative damage to cellular components, ultimately leading to DNA strand breaks and apoptosis in cancer cells. Epirubicin is frequently incorporated into chemotherapy regimens for a range of solid tumors, including breast cancer, gastric cancer, and certain lymphomas. While sharing many characteristics with doxorubicin, epirubicin is sometimes favored in specific protocols due to a potentially lower incidence of cumulative cardiotoxicity at equimolar doses, although cardiac monitoring remains a critical aspect of its safe administration. Its efficacy makes it a valuable component in both adjuvant and metastatic settings.

Uses

• Treatment of breast cancer.
• Management of gastric cancer.
• Used in lymphomas and leukemias.
• Intravesical therapy for bladder cancer.

Directions For Use

Administered intravenously by a healthcare professional. Dosage and schedule are tailored to the specific cancer and patient's condition.

Benefits

• Effective against various solid tumors.
• Potentially lower cardiotoxicity than doxorubicin.
• Induces DNA damage and cell death.
• Can be used in adjuvant and metastatic settings.
• Part of established chemotherapy protocols.
• Versatile in combination therapies.

Side Effects

• Myelosuppression (low blood counts)
• Nausea and vomiting
• Alopecia (hair loss)
• Mucositis/stomatitis
• Cardiotoxicity (heart damage)
• Fatigue/weakness
• Diarrhea
• Reddish urine (harmless)
• Injection site reactions
• Anorexia
• Amenorrhea
• Secondary acute myeloid leukemia

Safety Measures

• Alcohol - Avoid alcohol during epirubicin treatment as it may worsen gastrointestinal side effects and potentially increase liver burden.
• Pregnancy - Epirubicin is teratogenic and contraindicated in pregnancy due to the risk of severe fetal abnormalities. Women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is contraindicated during epirubicin therapy as the drug is excreted into breast milk and poses a risk of serious adverse effects to the nursing infant.
• Liver - Dose reduction is necessary in patients with hepatic impairment due to impaired metabolism and increased risk of toxicity. Liver function should be closely monitored.
• Kidney - No specific dose adjustments are generally required for mild to moderate renal impairment, but caution and monitoring are advised in severe cases.
• Lung - While not a primary lung toxicant, patients with pre-existing lung conditions should be monitored for any respiratory symptoms, especially if co-administered with other lung-toxic agents.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.